By: Rachael Rettner, LiveScience Senior Writer

Published: 06/19/2013 01:04 PM EDT on LiveScience


The human papillomavirus (HPV) vaccine appears to be having an early impact in the United States, reducing the percentage of teen girls infected with certain strains of the virus by more than half, a new study suggests.


After the vaccine was introduced in 2006, there was a 56 percent decrease in the rate of teen girls infected with the four HPV strains included in the vaccine (HPV 6, 11, 16, and 18), the study from the Centers for Disease Control and Prevention (CDC) found.


This decrease was greater than expected, given the low HPV vaccination rate. Between 2007 and 2010, only about a third of girls in this age group reported receiving at least one dose of HPV. The full series comprises three doses given over six months. [See HPV Vaccine: What If You Miss a Dose?]


"This report shows that HPV vaccine works well, and the report should be a wake-up call to our nation to protect the next generation by increasing HPV vaccination rates," Dr. Tom Frieden, director of the CDC, said in a statement.


Each year, HPV causes about 27,000 cancers, most commonly cervical cancer in women (19,000 cases) and oropharyngeal (throat) cancers in men (8,000 cases), the CDC says. Although the vaccine does not protect against all strains of HPV, it does protect against four strains, including the two strains (16 and 18) thought to cause about 70 percent of cervical cancers.


The study included information from 4,150 women ages 14 to 59 who were tested for HPV between 2003 and 2006, and 4,253 who were tested between 2007 and 2010.


Among girls ages 14 to 19, the percentage testing positive for at least one of the four HPV strains in the vaccine decreased from 11.5 percent in the group tested before 2006, to 5.1 percent in the group tested after 2006. No decrease was seen in other age groups.


Because the virus is spread through sex, the CDC recommends the vaccine be given before teens become sexually active. Girls and boys should be vaccinated at ages 11 or 12, the CDC says. (Those who were not vaccinated as adolescents are recommended to get the vaccine in their 20s, up to age 26.)


The larger-than-expected decrease in HPV prevalence could have been caused by several factors, including "herd immunity" -- protection of unvaccinated people that occurs because a critical portion of the population has been vaccinated.


"This decline is encouraging, given the substantial health and economic burden of HPV-associated disease," said study researcher Dr. Lauri Markowitz of the CDC.


Changes in sexual behavior could also affect HPV prevalence, but the study found similar rates of sexual activity among teen girls before and after the vaccine was introduced.


The study appears in the June issue of the Journal of Infectious Diseases.


Follow Rachael Rettner @RachaelRettner . Follow LiveScience @livescience , Facebook & Google+ . Original article on LiveScience.com .



Copyright 2013 LiveScience, a TechMediaNetwork company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. ]]>

Also on HuffPost:






  • An Abnormal Pap Test Means You Have High-Risk HPV


    Pap tests are the commonly accepted screening to prevent cervical cancer. A doctor scrapes a cell culture from a woman's cervix and then examines the cells for signs of abnormality. But just because a few of those cells appear abnormal, requiring further screening, doesn't necessarily mean that you've got a cancer-causing strain of HPV -- that's only one potential cause. "The difference could be due to local irritation, a non-HPV infection, a low-risk HPV type, or even a mistake in the preparation of the cell sample," writes the American Sexual Health Association.




  • Condom Use Prevents HPV


    HPV is passed via skin contact, rather than bodily fluid. For that reason, condoms can <em>lower</em> the risk of the disease, but they are not a sufficiently preventive measure, as they are for viruses like HIV and bacteria like gonorrhea.




  • Oral Sex Is Safe From Cancer Risk


    While the HPV-cancer connection most often relates to cervical health, a 2011 <em>Journal of Clinical Oncology</em> study found what doctors have long observed: There has been a surge in HPV-associated oral cancers. In fact, between 1988 and 2004, <a href="http://nyp.org/enews/oral-sex-hpv.html">HPV-associated oropharyngeal cancers rose 225 percent</a>. Oral sex is the primary culprit, making cancer screening of the mouth and esophagus another important test while visiting the doctor.




  • HPV Vaccine Means I Don't Have To Worry About Cervical Cancer


    The HPV vaccine protects against four strains of the virus that are most often associated with cancer and genital warts, but that doesn't mean it prevents cancer entirely. One concern within the medical community is that the vaccination will <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104818/">provide a false sense of security</a> and prevent innoculated men and women from receiving regular cancer screening. "Clearer information is needed concerning the incomplete protection offered by the vaccine, and that cervical screening will still be required," wrote a group of British public health researchers in the <em>Journal of Medical Screening</em>.




  • HPV Is A Serious, Life-Long Condition


    About 90 percent of HPV infections <a href="http://www.cdc.gov/vaccines/pubs/surv-manual/chpt05-hpv.pdf">are resolved by the body's immune system</a>.




  • Genital Warts Can Be Pre-Cancerous


    Some strains of HPV (<a href="http://www.ashastd.org/std-sti/hpv/myths-and-misconceptions.html">"low risk" types 6, 11, 42, 43 and 44</a>) cause benign growths known as genital warts and other strains (types 16, 18, 31 and 45) cause cancer of the cervix, vulva, vagina, penis, anus, or an area called the oropharynx, which includes the back of the throat, the base of the tongue and the tonsils. But that doesn't mean that one leads to the other -- genital warts, <a href="http://www.cdc.gov/std/hpv/stdfact-hpv.htm">which affect about one percent of the sexually active U.S. adult population</a> -- do not lead to cancer.




  • The HPV Vaccine Is For Girls


    The first HPV-preventive vaccine on the market, Gardasil, was approved by the FDA for use in girls in 2006 and <a href="http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm187003.htm">in boys three years later</a>. What's more, there are <em>two</em> FDA-approved vaccines for girls and women: Gardasil and Cervarix; while only Gardasil is available to boys and men. Still, HPV vaccination is the responsibility of all. Both the Centers for Disease Control and Prevention and the American Academy of Pediatrics both recommend the vaccine for boys for two primary reasons. First, inoculated boys will not be vectors for the disease, which can contribute to herd immunity and prevent dangerous infection in women. But more, the incidence of HPV-associated cancers that affect men is also growing, including anal and penile cancer and cancers of the mouth and throat.




  • Girls Who Receive An HPV Vaccine Will Be More Sexually Active


    <a href="http://www.time.com/time/nation/article/0,8599,1206813,00.html">Despite initial hand-wringing</a> that the vaccine could lead to promiscuity, a study of adolescent girls -- both those who had been inoculated and those who hadn't -- found no evidence that those who received the vaccination engaged in riskier behavior: they were no more likely to contract an STI, become pregnant or even seek out contraception -- a measure of intended sexual activity. "HPV vaccination in the recommended ages was not associated with increased sexual activity–related outcome rates," <a href="http://pediatrics.aappublications.org/content/early/2012/10/10/peds.2012-1516.abstract%7CSexual">the researchers wrote</a>.